GlassScriptPhysician profile
Seth Brandon Krantz
NPI 1881829992
$26,596.14
in general payments reported to CMS, 2019-2025
9 companies · $5,340 in 2025
The $5,340 reported for 2025 was more than what 83% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,126 · 2022: $15K · 2023: $3,150 · 2024: $2,077 · 2025: $5,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,196 · Food and Beverage: $1,326 · Consulting Fee: $1,050 · Travel and Lodging: $994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,196.39 |
| Food and Beverage | $1,326.08 |
| Consulting Fee | $1,050.00 |
| Travel and Lodging | $994.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $24,469.66 | 2019-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $1,188.16 | 2023-2024 | Imfinzi, Tagrisso |
| Medela LLC | $316.50 | 2024 | Art. 101030215 Thopaz+ Chest Drainage, Dominant Flex |
| Medtronic, INC. | $208.86 | 2024-2025 | Signet, Signia |
| Covidien LP | $127.04 | 2019 | |
| Merck Sharp & Dohme LLC | $124.93 | 2024 | Keytruda |
| Davol INC. | $85.82 | 2022 | |
| Conmed Corporation | $38.46 | 2024 | Airseal |
| Atricure, INC. | $36.71 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Krantz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.